Advanced search
1 file | 13.48 MB Add to list

Optimizing delivery of gene nanomedicines towards the retina via intravitreal administration

Thomas Martens (UGent)
(2014)
Author
Promoter
(UGent) , (UGent) and (UGent)
Organization
Keywords
single particle tracking, Vitreous humor, nanomedicines, hyaluronic acid, retinal gene therapy

Downloads

  • PhDThesis ThomasMartens.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 13.48 MB

Citation

Please use this url to cite or link to this publication:

MLA
Martens, Thomas. “Optimizing Delivery of Gene Nanomedicines Towards the Retina via Intravitreal Administration.” 2014 : n. pag. Print.
APA
Martens, T. (2014). Optimizing delivery of gene nanomedicines towards the retina via intravitreal administration. Ghent University. Faculty of Pharmaceutical Sciences, Ghent, Belgium.
Chicago author-date
Martens, Thomas. 2014. “Optimizing Delivery of Gene Nanomedicines Towards the Retina via Intravitreal Administration”. Ghent, Belgium: Ghent University. Faculty of Pharmaceutical Sciences.
Chicago author-date (all authors)
Martens, Thomas. 2014. “Optimizing Delivery of Gene Nanomedicines Towards the Retina via Intravitreal Administration”. Ghent, Belgium: Ghent University. Faculty of Pharmaceutical Sciences.
Vancouver
1.
Martens T. Optimizing delivery of gene nanomedicines towards the retina via intravitreal administration. [Ghent, Belgium]: Ghent University. Faculty of Pharmaceutical Sciences; 2014.
IEEE
[1]
T. Martens, “Optimizing delivery of gene nanomedicines towards the retina via intravitreal administration,” Ghent University. Faculty of Pharmaceutical Sciences, Ghent, Belgium, 2014.
@phdthesis{5763916,
  author       = {Martens, Thomas},
  keywords     = {single particle tracking,Vitreous humor,nanomedicines,hyaluronic acid,retinal gene therapy},
  language     = {eng},
  pages        = {XVI, 236},
  publisher    = {Ghent University. Faculty of Pharmaceutical Sciences},
  school       = {Ghent University},
  title        = {Optimizing delivery of gene nanomedicines towards the retina via intravitreal administration},
  year         = {2014},
}